Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biosimilar Monoclonal Antibody market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biosimilar Monoclonal Antibody market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar Monoclonal Antibody industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Therapeutics SA
Biocon Limited
Intas Pharmaceuticals Limited
BIOCAD BioXpress
Allergan plc
Celltrion Inc
Genor BioPharma Co Ltd
Boehringer Ingelheim GmbH
Dr Reddys Laboratories Ltd
Coherus BioSciences Inc
By Type:
Synthetic Chemicals
Biopharmaceuticals
Others
By End-User:
Chronic & Autoimmune Diseases
Oncology
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Monoclonal Antibody Market
-
1.3 Market Segment by Type
-
1.3.1 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Synthetic Chemicals from 2016 to 2027
-
1.3.2 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Biopharmaceuticals from 2016 to 2027
-
1.3.3 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Chronic & Autoimmune Diseases from 2016 to 2027
-
1.4.2 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.3 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilar Monoclonal Antibody Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilar Monoclonal Antibody by Major Types
-
3.4.1 Market Size and Growth Rate of Synthetic Chemicals
-
3.4.2 Market Size and Growth Rate of Biopharmaceuticals
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Biosimilar Monoclonal Antibody Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilar Monoclonal Antibody by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilar Monoclonal Antibody in Chronic & Autoimmune Diseases
-
4.4.2 Market Size and Growth Rate of Biosimilar Monoclonal Antibody in Oncology
-
4.4.3 Market Size and Growth Rate of Biosimilar Monoclonal Antibody in Others
5 Market Analysis by Regions
-
5.1 China Biosimilar Monoclonal Antibody Production Analysis by Regions
-
5.2 China Biosimilar Monoclonal Antibody Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biosimilar Monoclonal Antibody Landscape Analysis
-
6.1 North China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
6.2 North China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
7 Central China Biosimilar Monoclonal Antibody Landscape Analysis
-
7.1 Central China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
7.2 Central China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
8 South China Biosimilar Monoclonal Antibody Landscape Analysis
-
8.1 South China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
8.2 South China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
9 East China Biosimilar Monoclonal Antibody Landscape Analysis
-
9.1 East China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
9.2 East China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
10 Northeast China Biosimilar Monoclonal Antibody Landscape Analysis
-
10.1 Northeast China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
10.2 Northeast China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
11 Southwest China Biosimilar Monoclonal Antibody Landscape Analysis
-
11.1 Southwest China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
11.2 Southwest China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
12 Northwest China Biosimilar Monoclonal Antibody Landscape Analysis
-
12.1 Northwest China Biosimilar Monoclonal Antibody Landscape Analysis by Major Types
-
12.2 Northwest China Biosimilar Monoclonal Antibody Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Therapeutics SA
-
13.1.1 Therapeutics SA Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Biocon Limited
-
13.2.1 Biocon Limited Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Intas Pharmaceuticals Limited
-
13.3.1 Intas Pharmaceuticals Limited Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 BIOCAD BioXpress
-
13.4.1 BIOCAD BioXpress Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Allergan plc
-
13.5.1 Allergan plc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Celltrion Inc
-
13.6.1 Celltrion Inc Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Genor BioPharma Co Ltd
-
13.7.1 Genor BioPharma Co Ltd Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Boehringer Ingelheim GmbH
-
13.8.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Dr Reddys Laboratories Ltd
-
13.9.1 Dr Reddys Laboratories Ltd Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Coherus BioSciences Inc
-
13.10.1 Coherus BioSciences Inc Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Synthetic Chemicals from 2016 to 2027
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Biopharmaceuticals from 2016 to 2027
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Chronic & Autoimmune Diseases from 2016 to 2027
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilar Monoclonal Antibody Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilar Monoclonal Antibody
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilar Monoclonal Antibody by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilar Monoclonal Antibody by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Synthetic Chemicals
-
Figure Market Size and Growth Rate of Biopharmaceuticals
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilar Monoclonal Antibody by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilar Monoclonal Antibody by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Chronic & Autoimmune Diseases
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Others
-
Table China Biosimilar Monoclonal Antibody Production by Regions
-
Table China Biosimilar Monoclonal Antibody Production Share by Regions
-
Figure China Biosimilar Monoclonal Antibody Production Share by Regions in 2016
-
Figure China Biosimilar Monoclonal Antibody Production Share by Regions in 2021
-
Figure China Biosimilar Monoclonal Antibody Production Share by Regions in 2027
-
Table China Biosimilar Monoclonal Antibody Consumption by Regions
-
Table China Biosimilar Monoclonal Antibody Consumption Share by Regions
-
Figure China Biosimilar Monoclonal Antibody Consumption Share by Regions in 2016
-
Figure China Biosimilar Monoclonal Antibody Consumption Share by Regions in 2021
-
Figure China Biosimilar Monoclonal Antibody Consumption Share by Regions in 2027
-
Table North China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table North China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table North China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table North China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure North China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table Central China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table Central China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table Central China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table Central China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure Central China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table South China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table South China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table South China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table South China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure South China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table East China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table East China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table East China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table East China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure East China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table Northeast China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table Northeast China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table Northeast China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure Northeast China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table Southwest China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table Southwest China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table Southwest China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure Southwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table Northwest China Biosimilar Monoclonal Antibody Consumption by Types from 2016 to 2027
-
Table Northwest China Biosimilar Monoclonal Antibody Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2016
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2021
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by Types in 2027
-
Table Northwest China Biosimilar Monoclonal Antibody Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2016
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2021
-
Figure Northwest China Biosimilar Monoclonal Antibody Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Therapeutics SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Therapeutics SA
-
Figure Sales and Growth Rate Analysis of Therapeutics SA
-
Figure Revenue and Market Share Analysis of Therapeutics SA
-
Table Product and Service Introduction of Therapeutics SA
-
Table Company Profile and Development Status of Biocon Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon Limited
-
Figure Sales and Growth Rate Analysis of Biocon Limited
-
Figure Revenue and Market Share Analysis of Biocon Limited
-
Table Product and Service Introduction of Biocon Limited
-
Table Company Profile and Development Status of Intas Pharmaceuticals Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas Pharmaceuticals Limited
-
Figure Sales and Growth Rate Analysis of Intas Pharmaceuticals Limited
-
Figure Revenue and Market Share Analysis of Intas Pharmaceuticals Limited
-
Table Product and Service Introduction of Intas Pharmaceuticals Limited
-
Table Company Profile and Development Status of BIOCAD BioXpress
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD BioXpress
-
Figure Sales and Growth Rate Analysis of BIOCAD BioXpress
-
Figure Revenue and Market Share Analysis of BIOCAD BioXpress
-
Table Product and Service Introduction of BIOCAD BioXpress
-
Table Company Profile and Development Status of Allergan plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan plc
-
Figure Sales and Growth Rate Analysis of Allergan plc
-
Figure Revenue and Market Share Analysis of Allergan plc
-
Table Product and Service Introduction of Allergan plc
-
Table Company Profile and Development Status of Celltrion Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion Inc
-
Figure Sales and Growth Rate Analysis of Celltrion Inc
-
Figure Revenue and Market Share Analysis of Celltrion Inc
-
Table Product and Service Introduction of Celltrion Inc
-
Table Company Profile and Development Status of Genor BioPharma Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genor BioPharma Co Ltd
-
Figure Sales and Growth Rate Analysis of Genor BioPharma Co Ltd
-
Figure Revenue and Market Share Analysis of Genor BioPharma Co Ltd
-
Table Product and Service Introduction of Genor BioPharma Co Ltd
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
Table Company Profile and Development Status of Dr Reddys Laboratories Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddys Laboratories Ltd
-
Figure Sales and Growth Rate Analysis of Dr Reddys Laboratories Ltd
-
Figure Revenue and Market Share Analysis of Dr Reddys Laboratories Ltd
-
Table Product and Service Introduction of Dr Reddys Laboratories Ltd
-
Table Company Profile and Development Status of Coherus BioSciences Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Coherus BioSciences Inc
-
Figure Sales and Growth Rate Analysis of Coherus BioSciences Inc
-
Figure Revenue and Market Share Analysis of Coherus BioSciences Inc
-
Table Product and Service Introduction of Coherus BioSciences Inc
-
